INTRODUCTION
Mycobacterium avium subsp hominissuis (hereafter M. avium) is a common bacterial pathogen responsible for opportunistic infections in HIV-positive individuals, immunocompetent patients with underlying chronic lung diseases but in apparently healthy population [1, 2] . M. avium infects preferentially blood monocytes and tissue macrophages, and successfully survives within them. Pathogenic mycobacteria had adapted to unfavorable environments in the host by interfering with many of the defense mechanisms. When ingested by macrophages, M. avium prevents phagosome acidification [3] and fusion of phagosomes with lysosomes [4] . Bacterial components that play important roles in the early phase of infection are usually significant contributors to the adaptation to specific host niches. Previously, we have described genes regulated within macrophages by using M. avium promoter trap-GFP library [5] . In addition, the screening of an M. avium transposon library for clones deficient in uptake by human mononuclear cells identified both a PPE gene and a Pathogenicity Island (PI) [6] . The latter was associated with the ability of the bacterium to infect both amoeba and mammalian macrophages. The work also characterized the binding of M. avium protein encoded by the PI's ORF7 to actin, which results in cytoskeleton rearrangement and phosphorylation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The finding indicated that the ability to infect amoeba has equipped M. avium with novel virulence factors, many times not shared with other mycobacteria, including M. tuberculosis.
Recent evidence that GAPDH is involved in the vesicle transport of eukaryotic secreted proteins from the endoplasmic reticulum to the Golgi apparatus [7] suggests that the binding may be part of the pathogen's strategy to modify early events in vacuole trafficking.
Despite the knowledge obtained on M. avium genes associated with pathogenesis, the knowledge is still limited about mycobacterial virulence determinants. The In Vivo Expression Technology (IVET) has been developed to identify genes specifically expressed at different stages of infection in vivo. Different from the transposon approach, the IVET system does not require generating a chromosomal gene disruption. The IVET approach, based on lacZ and purA, was initially adapted for Salmonella typhimurium, and genes encoding for various virulence factors were identified in a mouse model of septicemia as well as in a rat model of chronic lung infection [8] . In vivo selection, based on auxotrophic markers, has also been reported for Pseudomonas aeruginosa [9] and Klebsiella pneumoniae [10] . Comparable CAT-based IVET strategies have been used to unveil novel virulence genes from Yersinia enterocolitica in a mouse model [11] . In addition, Mycobacterium tuberculosis genes, preferentially expressed during macrophage infection and in vivo, were identified through inhA-based IVET system [12, 13] . Although the IVET system has the ability to discover potential virulence determinants, it also has limitations, since many of the bacterial genes are associated with metabolism or other basic metabolic functions.
To select for M. avium virulence determinants involved in mechanisms of survival in different organs in mice, we developed an IVET system based on a quinolone-resistance gene as a selection marker. DNA gyrase, an enzyme essential for DNA super coiling and required for DNA replication and gene transcription, has been shown in mycobacteria to be a target for the quinolone family of drugs [14] . We then created a M. avium-promoter library upstream of the promoter-less resistant gyrA gene. The screening for M. avium tissue-specific virulence determinants expressed during the early phase of mouse infection, successfully identified M. avium genes regulated in vivo. Here we describe that one of those genes, expressed in the lung, spleen and liver is associated with the transport of M. avium proteins to the macrophage cytoplasm.
MATERIALS AND METHODS
Construction of IVET vector. Quinolone-resistant M. avium au2 and CDC1 clinical isolates were obtained from Dr. Clark Inderlied, Children's Hospital Los Angeles. The gyrA and gyrB genes were amplified using the sense (F) and antisense (R) primers provided in Table 1 , and sequenced to determine the point mutations. The E. coliMycobacterium IVET test vector was constructed from pMV261 His-tag containing plasmid by removing the hps60 promoter and inserting the strong sigma-70 (G13) promoter of M. marinum in NheI site. The gyrA-resistant gene with a point mutation at amino acid 87 was cloned in front of G13 promoter. In order to ensure that gyrA expression from the M. avium promoter-trap library was the direct result of activation of bacterial promoters, the trpA transcriptional terminator was placed, in advance, upstream of the G13 promoter. The IVET test vector named pLDG13GyrA and the control vector pLDGyrA, without the G13 promoter, were transformed into M. avium 104 and M. smegmatis mc 2 155. The M. avium wild-type and construct clones were then assayed for minimal inhibitory concentration (MIC) using the broth macrodilution method, as previously described [15] .
M. avium promoter-trap IVET library construction and in vivo screening. M. avium library was created by the following method: M. avium 104 genomic DNA was partially digested with Sau3AI restriction enzyme. After electrophoresis on a 1% agarose gel, fragments with 300-1500 bp size were extracted from the gel and cloned into the dephosphorylated BclI site of pLDGyrA plasmid upstream of the resistant gyrA gene (Fig. 1A ). University. Thirty-two mice were divided into four groups of eight control and twentyfour experimental mice (eight in three M. avium library pool infection groups) (Fig. 1B) .
While the control group was infected intravenously through the tail vein with 100 µl aliquots containing 10 7 colony forming units (CFU)/ml of wild-type M. avium 104, the experimental group was infected in a similar manner with IVET library pools of M.
avium. Two mice from each group were sacrificed at day 2 to establish the baseline infection. The rest of the animals were treated with moxifloxacin 150 mg/kg daily. After 2 weeks of treatment, mice were sacrificed from both control and experimental groups and spleens, livers and lungs were harvested. Surviving bacteria were isolated from all mice. At least one hundred colonies were screened from each mouse. The bacteria were quantified on 7H10 Middlebrook plates with or without kanamycin 400 μg/ml. No bacteria grew in control group of infected mice treated with 400 µg/ml of kanamycin. [5] . The intracellular bacteria were extracted from organ tissues as follow:
tissues were lysed with 0.5% SDS. Lysed cells from suspension were removed by differential centrifugation at 300 rpm for 5 min and the supernatant was removed and centrifuged at 3,500 rpm for 10 min to recover intact bacterial cells. The resulting bacterial pellets were re-suspended in Trisol (Life Technologies). RNA extraction was performed as previously described [5] . Samples were cleaned up with RNA clean kit (QIAGEN), treated with DNase, and concentration and quality of RNA was verified with A 260/280 ratio. Reverse transcription was performed using the SuperScript® III Reverse
Transcriptase kit (Life technologies) according to the manufacturer's protocol.
Quantitation of the expression of M. avium genes was carried out in the iCycler iQ (BioRad) with SYBR Green I assay using gene-specific primers ( Table 1 ). The calculated threshold cycle (Ct) for each gene amplification was normalized to the Ct of the 16S rRNA gene amplified from the corresponding sample and the fold change in gene expression was calculated as previously described [5] .
Mutant constructs.
To study the role of oppA, MAV_2941 and MAV_4320 in the pathogenesis of M. avium, the PCR-based mutations were generated in these genes.
Mutations were generated by simply including the desired nucleotide change in the primer sequence. More specifically, in the transport domain of the OppA aspartic acid (Asp) was replaced with glutamic acid (Glu) acid at 523aa position and asparagine (Asn) with lysine (Lys) at 527aa position. Two mutations at 2aa replacing glycine (Gly) with
Glu and at 73aa replacing arginine (Arg) with Lys were generated in MAV_2941; while in the MAV_4320 gene Glu was replaced with Gly at 4aa of N-terminus and Arg was changed with Gly at 42aa of C-terminus. The mutations in the gene were confirmed by sequencing before cloning. Mutated genes were then cloned into EcoRI site of the IVET test vector (pLDG13GyrA with His-tag) containing the resistant gyrA gene. The construct plasmids were transformed into the wild-type M. avium, as described above, and plated on 7H10 agar plates containing kanamycin (km) 400 µg/ml (marker for pLDG13). To confirm if km resistant clones of M. avium truly contained transformed constructs, PCR was performed for km and mutated M. avium genes using primers designed based on the plasmid sequence. In addition, M. avium mutated clones were grown in 7H9 broth and the western blot analysis was performed for mutated OppA, MAV_2941 and MAV_4320 proteins using His-antibody. To verify the differences in macrophage survival during infection with wild-type and mutated-overexpressed clones, THP-1 human monocyte cells (ATCC) were differentiated into macrophages by adding 50ng/ml of phorbol 12-myristate 13-acetate (PMA, Sigma Aldrich). Cells then were seeded at 80% confluency in 24-well plates, infected with either the M. avium wild-type, the wild-type containing the pLDG13GyrA vector or mutated-overexpressed clones for 1 hour. After bacterial infection, the wells were washed three times with HBSS and incubated with 200 µg/ml of amikacin for 1 h to kill and prevent the extracellular growth.
To establish the baseline infection, monolayers from each groups were lysed at 2 h infection with 0.25 % SDS for 10 min, serially diluted and plated onto Middlebrook 7H10 agar or containing appropriate antibiotics for colony forming unit (CFU) counts.
Rest of monolayers were incubated for 3 and 5 days, in presence of RPMI-1640
supplemented with 10% FBS and 0.6 µg/ml of ciprofloxacin to predominantly overexpress the mutated genes. After each time point, cells were lysed and dilutions were plated onto agar plates to determine the number of CFU. The CFUs were recorded from antibiotic-treated as well as untreated macrophages.
In vivo survival study. Thirty-six C57 beige mice were divided into two groups of eighteen and each group was infected intravenously with approximately 1 x 10 8 either M.
avium LDG13GyrA or OppA clone expressing mutated gene. Both groups received intraperitoneal injection of 150 mg/kg moxifloxacin every 2 days. The dose of moxifloxacin was based on the studies that show that treatment with 150 mg/kg is bactericidal for M. avium [16] . After two days of initial infection, six mice were harvested from each group and bacterial loads were determined in spleens by plating homogenized tissues onto 7H10 Middlebrook plates. Twenty-four mice (twelve in each group) were followed for additional three weeks. Then, the experiment was terminated and the bacterial loads were determined in the mouse spleens.
Protein-protein interaction screening by BacterioMatch II Two-Hybrid system. The Bacteriomatch II two-hybrid system (Stratagene, La Jolla CA) was used to construct and co-transform the bait pBT:oppA and the pray pTRG:MAC-library [17] into the reporter strain of E. coli. Transformants were plated onto LB agar plates containing 400 μg/ml carbenicillin, 12.5 μg/ml tetracycline, 34.5 μg/ml chloramphenicol, and 50 μg/ml kanamycin and incubated at 30°C overnight. Next day, all grown E. coli colonies were Fluorescence micrographs were captured with CCF2 filter set (Leica).
Statistical Analysis. The data represents the mean of three experiments ± the standard deviation. Significance of the differences between experimental groups and control groups was analyzed by the Student's t-test. A p value of < 0.05 was considered significant. the western blotting using His antibody (Fig.4C) . We then studied the survival of the mutant clone in THP-1 cells. As shown in Figure 3A the mutated clone was attenuated in macrophages compared with the wild-type bacterium.
RESULTS

Feasibility study of IVET vector in vitro.
To examine whether the mutated oppA clone was also attenuated in vivo, we infected C57BL/6 mice with M. avium carrying the plasmid pLDG13GryA (control) or M. avium oppA mutated clone and treated mice with 150 mg/kg of moxifloxacin to stimulate the expression of the mutated oppA gene. As observed in Figure 3B , at week 3 following infection, there was a significant attenuation of the oppA mutant. The results showed that while the control bacterium grew over time in the spleen, the mutated clone decreased in viability (p < 0.05). 
M. avium small proteins interacting with
M. avium MAV_2941 is secreted into the host cell. To determine whether MAV_2941
and MAV_4320 were secreted into the cytoplasm of host cells, we used the β-lactamase assay. THP-1 phagocytes were infected with M. avium clones expressing bla(-) lacking the signal peptide (Fig. 5A) , bla(+) containing the signal peptide (Fig. 5B) , MAV_2941:bla(-) (Fig. 5C ) or MAV_4320:bla(-) (Fig. 5D ). Using a cell-permeable fluorescent substrate CCF2-AM for β-lactamase, detectable hydrolysis was observed during bla(+), positive control, and MAV_2941:bla(-) infection ( Fig. 5B and C) at 20h post-infection. An endogenous β-lactamase hydrolysis of the substrate was quantified by cytofluorometry ( Fig. 5E ), confirming MAV_2941 protein secretion in human macrophages. We also analyzed the intracellular number of bacteria, which was found to be similar in all groups (Fig. 5F ). In addition, we fused both proteins to 6-His-tag of pJAM2 vector and over-expressed them in M. avium, as previously described [18] . The THP-1 cells were infected with M. avium clones for 24 h, and then macrophages were lysed, separated from the intracellular bacteria and processed for western blot analysis using His-tag antibody. As shown in Figure 5G , both proteins were expressed in M.
avium, but only MAV_2941 was detected in the cytoplasmic fraction of macrophages. maturation, has been previously described [33] . In Salmonella-containing vacuoles the activity of the effector SopB is linked to the inhibition of vacuole-lysosome fusion through dissociation of host endocytic trafficking proteins [34, 35] . During M.
Identification of the
tuberculosis infection, hVPS34 recruitment has a critical role in the phagosome maturation [36] . M. tuberculosis lipoarabinomannan and a PI3P phosphatase, SapM, have been shown to inhibit PI3P generation, effecting the normal phagosome recruitment [37] .
M. tuberculosis infection promotes targeting of immunity-related GTPases to the phagosome membranes via lipid-mediated interaction with PI3K and, thus, altering the phagolysosome biogenesis [38] . Future studies will address the possibility of MAV_2941 has a role in altering phagosome maturation. Organs were harvested and intracellular bacterial RNAs were used to determine the number of copies of cDNAs for target and reference genes. Quantitation of the expression of M. avium genes was carried out with SYBR Green I assay by Real-Time PCR detection system using gene-specific primers. The data represent the average of three independent experiments ± SD. clones was evaluated as **, p < 0.01 and *, p < 0.05 at the same time point of infection.
(C) Western blotting against His-tagged mutated OppA (57kDa), MAV_2941 (8kDa) and MAV_4320 (5kDa) proteins. M. avium clones, containing mutated genes in pLDG13GyrA vector, were grown in 7H9 broth with 0.6 µg/ml of ciprofloxacin (mutations described in Material and Method section). Cells were collected at exponential growth phase and lysed with rapid mechanical disruption in bead-beater. The pre-cleared cell lysates were separated on 16.5% Tricine gels and processed for western blot analysis using His primary antibody. 
